Micro-computed tomography (micro-CT), is a non-destructive 3D imaging technique that provides a clear understanding of the internal structure of a sample without destroying it and differs from ordinary clinical CT in its high resolution, which can reach the micrometer (μm) level. Micro-CT image live small animals without destroying the sample, obtaining detailed 3D structural information of the sample, thus displaying 3D images of various parts with a much higher resolution than clinical CT. Several ex vivo studies of the cerebral vasculature and anatomy of mice and rats, including one using an ex vivo MCAO rat brain, have demonstrated the high spatial resolution and signal-to-noise ratio of CT.
Fig. 1. High resolution micro-CT imaging allows brain neuroanatomical areas identification in physiological/pathological conditions (mouse stroke models). (Pinto et al., 2022)
Ace Therapeutics provides customers worldwide with high-resolution micro-CT imaging services for fine localization and quantification of ischemic lesions and edema in mouse preclinical stroke models. In vivo mice or brain tissue for scanning require contrast agents (e.g., osmium tetroxide, inorganic iodine, molybdenum phosphide) to assist in the imaging process, which can be customized to meet the specific needs of the customer.
Fixed and preserved tissue samples are scanned using a small animal Micro-CT scanning imaging system, and the microstructural parameters of the bone tissue in the target area are analyzed using the system's analysis software, with the analysis range of all specimens remaining the same.
Test samples and specific CT scanning requirements
Ace Therapeutics's micro-CT allows easy and fast 3D imaging of stroke mouse brains with high resolution and details, and is widely used to assess brain injury in preclinical stroke studies. We aim to accelerate your stroke research. If you are interested in our services, please do not hesitate to contact us!
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.